We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study

By LabMedica International staff writers
Posted on 29 Sep 2022
Print article
Image: Interest in POC technologies increased among health care professionals during pandemic (Photo courtesy of UMass Chan Medical School)
Image: Interest in POC technologies increased among health care professionals during pandemic (Photo courtesy of UMass Chan Medical School)

Few studies have looked at factors affecting adoption of point-of-care technologies (POCTs) among health care professionals. COVID-19 provided an opportunity to highlight the weaknesses in health care delivery systems, including a dependence on laboratory-based diagnostic technologies, and to rapidly develop novel technologies to address patient needs. Now, the findings of a new study suggest that interest among health care professionals in POCTs increased during the pandemic, with perceived applications of easy-to-use at-home, mobile or bedside devices in a broader range of diseases. Health care professionals also viewed the adoption of POCTs as facilitating the humanization of epidemiology - in other words, sharing control of disease diagnosis and management with patients, rather than continuing to be provider-driven.

So-called “gray swan events,” which are expected but unpredictable, can shift attitudes and behaviors, such as about how societies administer and provide access to health care as well as offer unique opportunities to stimulate innovation, the authors wrote. COVID-19 presented one such gray swan opportunity, according to researchers at UMass Chan Medical School (Worcester, MA, USA) and UMass Lowell (Lowell, MA, USA). In their current study, the researchers administered identical surveys to a network of health care professionals, researchers and medical device developers. The first survey was distributed from October 2019 to late March 2020. The second was distributed from late October through November 2020. Respondents were asked to name up to five conditions for which a POCT could help make a diagnosis of a disease; name up to five conditions for which a POCT could help them monitor or manage a disease; and which characteristics of POCT are most important when incorporating it into their regular practice.

Prior to the COVID-19 pandemic, health care professionals identified 18 medical condition categories for which POCTs could be used to diagnose a disease. Endocrine disorders, including diabetes mellitus, featured prominently among these, followed by infectious disease, cardiovascular and hematology conditions. Following COVID-19’s designation as a pandemic, health care professionals identified 20 medical conditions for which POCTs could be used to diagnose a disease. Infectious disease and cardiovascular-related medical conditions rose to the center of this network, followed by endocrine, respiratory and hematology conditions. Perceptions of POCTs to manage or monitor a disease also shifted. Before the pandemic, health care professionals identified cardiovascular disease as the category for which POCT was most helpful for monitoring or managing. Once COVID-19 was designated a pandemic, endocrine diseases were identified as the condition for which POCT was most useful. However, metabolic diseases experienced the greatest increase in interest.

“I believe there are many different reasons as to why point-of-care technology became more important after COVID; because the more you get used to using a technology, the more you see the benefits of having that technology,” said senior author Denise R. Dunlap, PhD, associate professor of global strategy, entrepreneurship and innovation at UMass Lowell’s Manning School of Business.

“COVID has made it so not only were point-of-care tests needed for COVID testing, but point-of-care technologies have been needed because health care is becoming more decentralized,” added UMass Chan researchers David D. McManus, MD, the Richard M. Haidack Professor in Medicine and chair and professor of medicine. “There’s no question from our paper that you could see changes in terms of acceptance of these technologies and integration into mainstream health care. People thought they were extras, but now that’s an essential ingredient in health care.”

Related Links:
UMass Chan Medical School 
UMass Lowell 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more